The elderly patient with surgically resected non-small cell lung cancer - A distinct situation?

被引:21
|
作者
Sterlacci, William [1 ]
Stockinger, Richard [1 ]
Schmid, Thomas [2 ]
Bodner, Johannes [2 ]
Hilbe, Wolfgang [3 ]
Waldthaler, Christian [3 ]
Oberaigner, Wilhelm [4 ]
Tzankov, Alexandar [5 ]
Fiegl, Michael [3 ]
机构
[1] Univ Teaching Hosp Feldkirch, Inst Pathol, A-6807 Feldkirch, Austria
[2] Med Univ Innsbruck, Dept Visceral Transplantat & Thorac Surg, A-6020 Innsbruck, Austria
[3] Med Univ Innsbruck, Dept Internal Med, Div Hematol & Oncol, A-6020 Innsbruck, Austria
[4] TILAK, Inst Clin Epidemiol, A-6020 Innsbruck, Austria
[5] Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland
关键词
Non-small cell lung cancer; Elderly; Recurrence; Surgical resection; Clinical and pathological characteristics; MORBIDITY; AGE; MANAGEMENT; PROGNOSIS; MORTALITY; SURVIVAL; OUTCOMES; RISK;
D O I
10.1016/j.exger.2011.12.008
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
The worldwide population shift towards older ages will inevitably lead to more elderly patients being diagnosed with cancer. Lung cancer is the number one cause for cancer mortality and surgical resection is the treatment of choice whenever possible. This study investigates whether elderly patients with non-small cell lung cancer (NSCLC) are characterized by distinct clinical and pathologic features and different clinical course after resection. Special emphasis is placed on disease recurrence, which is an important, but rarely described parameter for biological tumor behavior. Sex, stage, histology, differentiation grade, smoking status, performance status, hemoglobin, C-reactive protein, lactate dehydrogenase, Ki-67 index, recurrent disease and overall survival were analyzed in 383 surgically resected NSCLC patients. Calculations were performed comparing patients <70 to >= 70 years. A postoperative follow-up period of 15 years enabled detailed correlations. Rate of disease recurrence and disease-free survival did not differ between any age groups and was not influenced by clinico-pathologic parameters. Elderly patients with a Ki-67 index of >3% were associated with significantly decreased overall survival time when compared to younger patients (36.3 and 47.3 months respectively, p = 0.029). The biological behavior of NSCLC as reflected by characteristics of disease recurrence is similar for surgically resected patients among different age groups and does not warrant specific recommendations for the elderly surgical patient. The Ki-67 index offers prognostic information for overall survival in the elderly. (C) 2011 Elsevier Inc. All rights reserved,
引用
收藏
页码:237 / 242
页数:6
相关论文
共 50 条
  • [1] Adjuvant chemotherapy for surgically resected non-small cell lung cancer
    Heon, Stephanie
    Johnson, Bruce E.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2012, 144 (03): : S39 - S42
  • [2] The value of tumor volume in surgically resected non-small cell lung cancer
    Iwasaki, A
    Shirakusa, T
    Enatsu, S
    Maekawa, S
    Hamada, T
    Hamasaki, M
    THORACIC AND CARDIOVASCULAR SURGEON, 2006, 54 (02): : 112 - 116
  • [3] Prognostic factors for surgically resected non-small cell lung cancer with cavity formation
    Shigefuku, Shunsuke
    Kudo, Yujin
    Yunaiyama, Daisuke
    Matsubayashi, Jun
    Park, Jinho
    Nagao, Toshitaka
    Shimada, Yoshihisa
    Saji, Hisashi
    Hagiwara, Masaru
    Okano, Tetsuya
    Kakihana, Masatoshi
    Kajiwara, Naohiro
    Ohira, Tatsuo
    Ikeda, Norihiko
    JOURNAL OF THORACIC DISEASE, 2018, 10 (02) : 973 - +
  • [4] Prognostic factors for recurrence in patients with surgically resected non-small cell lung cancer
    Satoh, Hiroaki
    Iguchi, Kesato
    Nakamura, Ryota
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2022, 26 (04): : 314 - 314
  • [5] Prognostic role of nitrotyrosines in surgically resected non-small cell lung cancer (NSCLC)
    Toschi, L.
    Colombo, P.
    Soldani, C.
    Giordano, L.
    Finocchiaro, G.
    Siracusano, L.
    Gianoncelli, L.
    Incarbone, M.
    Destro, A.
    Alloisio, M.
    Terracciano, L.
    Varella-Garcia, M.
    Cappuzzo, F.
    Roncalli, M.
    Viola, A.
    Santoro, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [6] Impact of Previous Malignancy on Outcome in Surgically Resected Non-Small Cell Lung Cancer
    Nakao, Keita
    Anraku, Masaki
    Karasaki, Takahiro
    Kitano, Kentaro
    Nagayama, Kazuhiro
    Sato, Masaaki
    Nakajima, Jun
    ANNALS OF THORACIC SURGERY, 2019, 108 (06): : 1671 - 1677
  • [7] Prognostic Factors for Surgically Resected Non-Small Cell Lung Cancer with Cavity Formation
    Shigefuku, S.
    Kudo, Y.
    Yunaiyama, D.
    Matsubayashi, J.
    Park, J.
    Nagao, T.
    Shimada, Y.
    Hagiwara, M.
    Saji, H.
    Okano, T.
    Kakihana, M.
    Kajiwara, N.
    Ohira, T.
    Ikeda, N.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2408 - S2408
  • [8] Prognostic factors for recurrence in patients with surgically resected non-small cell lung cancer
    Moskalenko, Yuliia
    Smorodska, Olga
    Deineka, Volodymyr
    Kravets, Oleksandr
    Moskalenko, Roman
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2022, 26 (03): : 239 - 246
  • [9] The Clinical Significance of Immune-Nutritional Parameters in Surgically Resected Elderly Patients with Non-Small Cell Lung Cancer
    Shoji, F.
    Miura, N.
    Akamine, T.
    Matsubara, T.
    Kozuma, Y.
    Haratake, N.
    Takamori, S.
    Katsura, M.
    Takada, K.
    Toyokawa, G.
    Takenaka, T.
    Yamazaki, K.
    Okamoto, T.
    Takeo, S.
    Maehara, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2344 - S2344
  • [10] c-MET as a biomarker in patients with surgically resected non-small cell lung cancer
    Tsakonas, Georgios
    Botling, Johan
    Micke, Patrick
    Rivard, Chris
    LaFleur, Linnea
    Mattsson, Johanna
    Boyle, Teresa
    Hirsch, Fred R.
    Ekman, Simon
    LUNG CANCER, 2019, 133 : 69 - 74